Changes in Permanent Contraception Procedures Among Young Adults Following the Dobbs Decision

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, APRIL 12, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.0424?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041224

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Researchers observed an abrupt increase in permanent contraception procedures among adults ages 18 to 30 following Dobbs. The increase in procedures for female patients was double that for male patients. These patterns offer insights into the gendered dynamics of permanent contraceptive use and may reflect the disproportionate health, social, and economic consequences of compulsory pregnancy on women and people with the capacity to become pregnant. 

Authors: Jacqueline E. Ellison, Ph.D., of the University of Pittsburgh School of Public Health, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2024.0424)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Physician Empathy and Chronic Pain Outcomes

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 11, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.6026?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study that included 1,470 adults with chronic low back pain, physician empathy was associated with better outcomes over 12 months. Greater efforts to cultivate and improve physician empathy appear warranted. 

Authors: John C. Licciardone, D.O., M.S., M.B.A., of the University of North Texas Health Science Center at Fort Worth, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.6026)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Second Primary Breast Cancer in Young Breast Cancer Survivors

Posted by Jim Michalski

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 11, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0286?guestAccessKey=69248d69-50fe-42e8-9b30-327dba0a1eb6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041124

 

About The Study: The results of this study suggest that young breast cancer survivors without a germline pathogenic variant have a low risk of developing a second primary breast cancer in the first 10 years after diagnosis. Findings from germline genetic testing may inform treatment decision-making and follow-up care considerations in this population. 

Authors: Kristen D. Brantley, Ph.D., M.P.H., of the Harvard T. H. Chan School of Public Health in Boston, is the corresponding author. 

 

(doi:10.1001/jamaoncol.2024.0286)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.0384?guestAccessKey=b4bbfae2-1290-418b-98c7-5ef99421b33c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041024

No Comments

Filed under:

Traumatic Brain Injuries After Falls From Height vs Falls at the US-Mexico Border Wall

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2024.0008?guestAccessKey=febbf877-adaf-4817-b7e4-a09ce3792fc6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041024

No Comments

Filed under:

Trends in Deaths of Despair by Race and Ethnicity

Posted by Jim Michalski

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, APRIL 10, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.0303?guestAccessKey=154feab9-7ef2-4fb8-bc4e-fc9a02423831&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041024

 

About The Study: As of 2022, the midlife mortality rates from deaths of despair (deaths from suicide, drug overdose, and alcoholic liver disease) among Black individuals were higher than rates among white individuals, and rates among American Indian or Alaska Native individuals remained higher than rates in the other groups. Rising inequalities in deaths of despair among American Indian or Alaska Native and Black individuals were largely attributable to disproportionate early mortality from drug- and alcohol-related causes, which increased leading up to and during the COVID-19 pandemic. 

Authors: Joseph Friedman, Ph.D., M.P.H., of the University of California, Los Angeles, is the corresponding author.

 

(10.1001/jamapsychiatry.2024.0303)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Race, Ethnicity, and Delayed Time to COVID-19 Testing Among Health Care Workers

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, APRIL 10, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.5697?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=041024

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this cross-sectional study of health care personnel (HCP), compared with non-Hispanic white HCP and clinical HCP with graduate degrees, non-Hispanic Black HCP, non-Hispanic HCP of other races, and HCP of all other professional and education backgrounds were more likely to have delayed COVID-19 testing. These findings suggest that time to testing may serve as a valuable metric in evaluating sociodemographic disparities in the response to COVID-19 and future health mitigation strategies. 

Authors: DaMarcus E. Baymon, M.D., of Brigham and Women’s Hospital in Boston, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.5697)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4682?guestAccessKey=2972c24e-b221-49f8-81f1-209429614631&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041024

No Comments

Filed under:

Firearm Ownership and Support for Political Violence in the United States

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, APRIL 9, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.3623?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040924

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this survey study with 12,000 participants, firearm owners were only moderately more supportive of political violence than nonowners. Recent purchasers and owners who always or nearly always carried firearms in public were more supportive of and willing to engage in political violence than other subsets of firearm owners. These findings can guide risk-based prevention efforts. 

Authors: Garen J. Wintemute, M.D., M.P.H., of the UC Davis School of Medicine in Sacramento, California, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.3623)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Top Factors in Nurses Ending Health Care Employment Between 2018 and 2021

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, APRIL 9, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4121?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040924

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The top contributing factors for leaving health care employment were planned retirement, burnout, insufficient staffing, and family obligations in this cross-sectional study of 7,887 nurses. The leading reasons signal opportunities for employers to reattract an existing nurse workforce and retain currently employed nurses. 

Authors: K. Jane Muir, Ph.D., R.N., F.N.P.-B.C., of the University of Pennsylvania in Philadelphia, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4121)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression

Posted by Jim Michalski

JAMA Cardiology

EMBARGOED FOR RELEASE: 10:45 A.M. (ET), SATURDAY, APRIL 6, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the American College of Cardiology’s Annual Scientific Session. 

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.0595?guestAccessKey=467632d9-aa45-4d7e-9606-fb432c66d48c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040624

 

About The Study: In this cohort study of patients without severe aortic stenosis undergoing echocardiography or cardiac magnetic resonance imaging, a new artificial intelligence (AI)-based video biomarker was independently associated with aortic stenosis development and progression, enabling opportunistic risk stratification across cardiovascular imaging modalities as well as potential application on handheld devices. 

Authors: Rohan Khera, M.D., M.S., of the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.

 

(doi:10.1001/jamacardio.2024.0595)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures

Posted by Jim Michalski

JAMA Cardiology

EMBARGOED FOR RELEASE: 10:45 A.M. (ET), SATURDAY, APRIL 6, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the American College of Cardiology’s Annual Scientific Session. 

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.0873?guestAccessKey=66be9cf8-263a-4a9d-8432-42280b8a0a49&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040624

 

About The Study: This systematic review and meta-analysis including data on 1.1 million cases of infective endocarditis found that antibiotic prophylaxis was associated with a reduced risk of infective endocarditis following invasive dental procedures in individuals at high risk but not in those at moderate or low/unknown risk. Currently, there is insufficient data to support any benefit of antibiotic prophylaxis in individuals at moderate risk. 

Authors: Federica Turati, Ph.D., of the Università degli Studi di Milano in Milan, Italy, and Katherine France, D.M.D., M.B.E., of the University of Pennsylvania in Philadelphia, are the corresponding authors.

 

(doi:10.1001/jamacardio.2024.0873)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia

Posted by Jim Michalski

JAMA Cardiology

EMBARGOED FOR RELEASE: 9 A.M. (ET), SUNDAY, APRIL 7, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the American College of Cardiology’s Annual Scientific Session. 

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.0959?guestAccessKey=0ae3b504-dfb6-4e89-8883-c74f4f743edf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040724

 

About The Study: This randomized clinical trial demonstrates the potential clinical utility of plozasiran, an investigational APOC3-targeted small interfering–RNA drug, to reduce triglyceride level in patients with severe hypertriglyceridemia. Additional studies will be required to determine whether plozasiran favorably modulates the risk of severe hypertriglyceridemia-associated complications. 

Authors: Daniel Gaudet, M.D., Ph.D., of the Université de Montréal, is the corresponding author.

 

(doi:10.1001/jamacardio.2024.0959)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease

Posted by Jim Michalski

JAMA Cardiology

EMBARGOED FOR RELEASE: 9 A.M. (ET), SUNDAY, APRIL 7, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the American College of Cardiology’s Annual Scientific Session. 

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2024.0468?guestAccessKey=69f06239-d636-4ea3-8197-2a0166603e1b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040724

 

About The Study: High-dose influenza vaccine elicited a more robust humoral response in patients with heart failure or prior myocardial infarction enrolled in the INVESTED randomized clinical trial, with no association between seroconversion status and the risk for cardiopulmonary hospitalizations or all-cause mortality. Vaccination to prevent influenza remains critical in high-risk populations. 

Authors: Scott D. Solomon, M.D., of Brigham and Women’s Hospital and Harvard Medical School in Boston, and Orly Vardeny, Pharm.D., M.S., of the University of Minnesota in Minneapolis, are the corresponding authors.

 

(doi:10.1001/jamacardio.2024.0468)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, APRIL 9, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.3172?guestAccessKey=32d8014d-f026-4985-9e72-d514cb2f81dc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040924

 

About The Study: Acetaminophen use during pregnancy was not associated with children’s risk of autism, attention-deficit/hyperactivity disorder (ADHD), or intellectual disability in sibling control analysis. This suggests that associations observed in other models may have been attributable to familial confounding. 

Authors: Brian K. Lee, Ph.D., of Drexel University in Philadelphia, is the corresponding author.

 

(doi:10.1001/jama.2024.3172)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Telephone-Based Guideline-Directed Medical Therapy Optimization in Navajo Nation

Posted by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 5 P.M. (ET), SUNDAY, APRIL 7, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the American College of Cardiology’s Annual Scientific Session. 

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.1523?guestAccessKey=bf7cfaa1-998e-4e8d-b030-3ae57fd7aa0e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040724

 

About The Study: In this randomized clinical trial including 103 American Indian patients, a telephone-based strategy of remote initiation and titration for outpatients with heart failure with reduced ejection fraction led to improved rates of guideline-directed medical therapy at 30 days compared with usual care. This low-cost strategy could be expanded to other rural settings where access to care is limited. 

Authors: Lauren A. Eberly, M.D., M.P.H., of the Indian Health Service in Gallup, New Mexico, is the corresponding author.

 

(doi:10.1001/jamainternmed.2024.1523)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 6:30 P.M. (ET), SUNDAY, APRIL 7, 2024

Media advisory: The full study and editorial are linked to this news release. This study is being released to coincide with presentation at the American Association for Cancer Research Annual Meeting 2024.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.5814?guestAccessKey=c6b0b8b9-a1d0-436b-bab5-dfd9275c5161&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040724

 

About The Study: In this systematic review and meta-analysis that included 41 randomized clinical trials of cancer screening, incidence of late-stage cancer may be a suitable alternative end point to cancer-specific mortality for some cancer types, but is not suitable for others. These results have implications for clinical trials of multicancer screening tests. 

Authors: Hilary A. Robbins, Ph.D., M.H.S., M.S.P.H., of the International Agency for Research on Cancer in Lyon, France, is the corresponding author.

 

(doi:10.1001/jama.2024.5814)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 2 P.M. (ET), SUNDAY, APRIL 7, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the American Association for Cancer Research Annual Meeting 2024.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2396?guestAccessKey=15ee7076-4bec-43b0-8c24-bb84c7c24bdc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040724

 

About The Study: Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival or quality of life within five years of accelerated approval.
Patients should be clearly informed about the cancer drugs that use the accelerated approval pathway and do not end up showing benefits in patient-centered clinical outcomes. 

Authors: Aaron S. Kesselheim, M.D., J.D., M.P.H., of Brigham and Women’s Hospital and Harvard Medical School in Boston, is the corresponding author.

 

(doi:10.1001/jama.2024.2396)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

In-Person Visits Before Initiation of Telemedicine for Mental Illness

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.0234?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040524

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

No Comments

Filed under:

Drug Shortages Prior to and During the COVID-19 Pandemic

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, APRIL 5, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4246?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Supply chain issues associated with drug shortages increased at the beginning of the COVID-19 pandemic according to the results of this national cross-sectional study. Ongoing policy work is needed to protect U.S. drug supplies from future shocks and to prioritize clinically valuable drugs at greatest shortage risk. 

Authors: Katie J. Suda, Pharm.D., M.S., of the University of Pittsburgh School of Medicine, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4246)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Magnetic Resonance Imaging in Prostate Cancer Screening

Posted by Jim Michalski

JAMA Oncology

EMBARGOED FOR RELEASE: 2 A.M. (ET), FRIDAY, APRIL 5, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the 39th Annual European Association of Urology Congress.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0734?guestAccessKey=631de277-a867-4cac-926c-f85b41ec167e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040524

 

About The Study: The results of this systematic review and meta-analysis suggest that integrating magnetic resonance imaging (MRI) in prostate cancer screening pathways is associated with a reduced number of unnecessary biopsies and overdiagnosis of insignificant prostate cancer while maintaining clinically significant prostate cancer detection as compared with prostate-specific antigen (PSA)-only screening. 

Authors: Shahrokh F. Shariat, M.D., D.Dr.(hc), of Medical University Vienna in Vienna, is the corresponding author. 

 

(doi:10.1001/jamaoncol.2024.0734)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 4:15 A.M. (ET), SATURDAY, APRIL 6, 2024

Media advisory: The full study and editorial are linked to this news release. This study is being released to coincide with presentation at the 39th Annual European Association of Urology Congress.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.3841?guestAccessKey=0ec76eb2-a05b-4ae3-b31c-7a662e979189&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040624

 

About The Study: In this preliminary descriptive report from an ongoing randomized clinical trial, one additional high-grade cancer per 196 men and one low-grade cancer per 909 men were detected among those randomized to be invited to undergo a single prostate cancer screening intervention compared with those not invited to undergo screening. These preliminary findings from a single round of screening should be interpreted cautiously, pending results of the study’s primary mortality outcome. 

Authors: Anssi Auvinen, M.D., Ph.D., of Tampere University in Tampere, Finland, is the corresponding author.

 

(doi:10.1001/jama.2024.3841)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

PSA Screening and 15-Year Prostate Cancer Mortality

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 2:30 A.M. (ET), SATURDAY, APRIL 6, 2024

Media advisory: The full study is linked to this news release. This study is being released to coincide with presentation at the 39th Annual European Association of Urology Congress.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4011?guestAccessKey=4f006acb-c40d-46ea-83d9-38c1f5b3815d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040624

 

About The Study: A single invitation for prostate-specific antigen (PSA) screening compared with standard practice without routine screening reduced prostate cancer deaths at a median follow-up of 15 years in this secondary analysis of a randomized clinical trial. However, the absolute reduction in deaths was small. 

Authors: Richard M. Martin, B.M., B.S., Ph.D., of the University of Bristol in Bristol, United Kingdom, is the corresponding author.

 

(doi:10.1001/jama.2024.4011)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Prevalence of Type 1 Diabetes Among US Children and Adults by Age, Sex, Race, and Ethnicity

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2103?guestAccessKey=439e631f-6510-4992-9846-614cad42606b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040424

No Comments

Filed under:

Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0194?guestAccessKey=db5b4e6f-349e-478c-83a3-2bdb4adaa64a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040424

No Comments

Filed under:

Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 4, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4386?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040424

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this randomized crossover clinical trial with 62 participants, non-hospitalized patients with post-COVID condition (PCC) generally tolerated exercise with preserved cardiovascular function but showed lower aerobic capacity and less muscle strength than the control group. They also showed signs of postural orthostatic tachycardia and myopathy. The findings suggest cautious exercise adoption could be recommended to prevent further skeletal muscle deconditioning and health impairment in patients with PCC. 

Authors: Andrea Tryfonos, Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4386)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Severity of RSV vs COVID-19 and Influenza Among Hospitalized US Adults

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 4, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4954?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040424

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Among 7,998 adults hospitalized during the 16 months before the first respiratory syncytial virus (RSV) vaccine recommendations, RSV disease was less common but similar in severity compared with COVID-19 or influenza disease among unvaccinated patients and more severe than COVID-19 or influenza disease among vaccinated patients for the most serious outcomes of invasive mechanical ventilation or death. 

Authors: Diya Surie, M.D., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4954)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Disparities in Mentorship and Implications for Surgical Resident Education and Wellness

Posted by Jim Michalski

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, APRIL 3, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2024.0533?guestAccessKey=6908c87f-eee0-4f66-8ee0-55e56b61c11c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040324

 

About The Study: In a survey study of residents of all accredited general surgery programs, one-third of trainees reported lack of meaningful mentorship, particularly non-white or Hispanic trainees. Although education and wellness are multifactorial issues, mentorship was associated with improvement; thus, efforts to facilitate mentorship are needed, especially for minoritized residents. 

Authors: Yue-Yung Hu, M.D., M.P.H., of Northwestern University in Chicago, is the corresponding author.

 

(doi:10.1001/jamasurg.2024.0533)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Socioecologic Factors and Racial Differences in Breast Cancer Prognostic Scores

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, APRIL 3, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4862?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040324

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this study suggest that the consequences of structural racism extend beyond inequities in health care to drive disparities in breast cancer outcome. Additional research is needed with more comprehensive social and environmental measures to better understand the influence of social determinants on aggressive estrogen receptor-positive tumor biology among racial and ethnic minoritized women from disadvantaged and historically marginalized communities. 

Authors: Gregory S. Calip, Pharm.D., M.P.H., Ph.D., of the University of Southern California in Los Angeles, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4862)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, APRIL 2, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4525?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040224

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: High levels of glucose and triglycerides and low levels of high-density lipoprotein were associated with future risk of depression, anxiety, and stress-related disorders in this study of more than 200,000 participants. These findings may support closer follow-up of individuals with metabolic dysregulations for the prevention and diagnosis of psychiatric disorders. 

Authors: Charilaos Chourpiliadis, M.D., of the Karolinska Institutet in Stockholm, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4525)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, APRIL 2, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4611?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040224

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study of 9,740 surveillance colonoscopies among 9,601 adults ages 70 to 85 with prior colorectal adenoma, colorectal cancer detection was rare regardless of prior adenoma finding, whereas the advanced neoplasia yield was 12% overall. Yields were higher among those with a prior advanced adenoma than among those with prior nonadvanced adenoma and did not increase significantly with age. These findings can help inform whether to continue surveillance colonoscopy in older adults. 

Authors: Jeffrey K. Lee, M.D., M.P.H., of Kaiser Permanente Northern California in Oakland, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4611)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Interrupted Time Series Analysis of Bar/Tavern Closing Hours and Violent Crime

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.0255?guestAccessKey=d2ed82e6-9b3f-42b4-972c-76e5f8154c28&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040124

No Comments

Filed under:

Clinical Reasoning of a Generative AI Model Compared With Physicians

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.0295?guestAccessKey=ea6709a9-da51-45cf-ab92-9942dc20c4df&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040124

No Comments

Filed under:

Suicidal Thoughts and Behaviors Among Children and Adolescents With Autism Spectrum Disorder

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.0207?guestAccessKey=01764ef2-906b-40fa-bff2-9ef9c431bd1d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040124

No Comments

Filed under:

Exposure to Polybrominated Diphenyl Ethers and Risk of All-Cause and Cause-Specific Mortality

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, APRIL 1, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.3127?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this nationally representative cohort study, polybrominated diphenyl ether (PBDE) exposure was significantly associated with an increased risk of cancer mortality. Since the 1970s, PBDEs have been used as flame retardants in a wide array of consumer products, such as building materials, furnishings, and electronics. Further studies are needed to replicate the findings and determine the underlying mechanisms. 

Authors: Wei Bao, M.D., Ph.D., and Buyun Liu, M.D., Ph.D., of the University of Science and Technology of China in Hefei, Anhui, China, are the corresponding authors. 

 

(doi:10.1001/jamanetworkopen.2024.3127)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Binge Drinking Among Sports Gamblers

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, APRIL 1, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.5473?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this survey study, binge drinking in both men and women was reported at greater frequency among sports wagering individuals compared with nongamblers and non–sports gamblers.  

Authors: Joshua B. Grubbs, Ph.D., of the University of New Mexico in Albuquerque, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.5473)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, APRIL 1, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4266?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this study suggest that smartphones could offer a feasible, reliable, valid, and scalable solution for remote evaluations of frontotemporal lobar degeneration, a neurodegenerative pathology causing early-onset dementia syndromes, and may improve early detection. Smartphone assessments should be considered as a complementary approach to traditional in-person trial designs. Future research should validate these results in diverse populations and evaluate the utility of these tests for longitudinal monitoring. 

Authors: Adam M. Staffaroni, Ph.D., of the University of California, San Francisco, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4266)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Prevalence of Medical Payment Products Promoted on Hospitals’ Websites

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.0231?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032924

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

No Comments

Filed under:

Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 29, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.5429?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032924

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The findings of this study suggest that biosimilar competition was not consistently associated with lower out-of-pocket costs for commercially insured outpatients, highlighting the need for targeted policy interventions to ensure that the savings generated from biosimilar competition translate into increased affordability for patients who need biologics.

Authors: Benjamin N. Rome, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2024.5429)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Reports of COVID-19 Vaccine Adverse Events in Predominantly Republican vs Democratic States

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 29, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4177?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032924

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This study found that the more states were inclined to vote Republican, the more likely their vaccine recipients or their clinicians reported COVID-19 vaccine adverse events. These results suggest that either the perception of vaccine adverse events or the motivation to report them was associated with political inclination. 

Authors: David A. Asch, M.D., M.B.A., of the University of Pennsylvania in Philadelphia, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4177)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, APRIL 1, 2024

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2759?guestAccessKey=3287dfc0-989f-44b4-9693-08051fff05a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040124

 

About The Study: In this quality improvement study of 35 health care facilities in Orange County, California, using quasi-experimental design, chlorhexidine bathing and nasal decolonization were associated with significantly lower multidrug-resistant organism prevalence and incident clinical cultures. Infection-related hospitalizations, associated costs, and deaths among nursing home residents also decreased. 

Authors: Susan S. Huang, M.D., M.P.H., of the University of California Irvine School of Medicine in Irvine, is the corresponding author.

 

(doi:10.1001/jama.2024.2759)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Machine Learning–Based Prediction of Hospitalization During Chemoradiotherapy With Daily Step Counts

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.0014?guestAccessKey=c30dbd7d-ff8f-49b0-b150-0452a6fb426f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032824

No Comments

Filed under:

Bias Reduction Practices in Underrepresented Groups in Ophthalmology Resident Recruitment

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2024.0394?guestAccessKey=4ef2f565-871d-45d9-b338-8f372945919c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032824

No Comments

Filed under:

Perspectives of Oncologists on the Ethical Implications of Using AI for Cancer Care

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 28, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.4077?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032824

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this survey study of 204 oncologists, few reported that patients needed to understand artificial intelligence (AI) models, but most agreed that patients should consent to their use, and many tasked patients with choosing between physician- and AI-recommended treatment regimens. These findings suggest that the implementation of AI in oncology must include rigorous assessments of its effect on care decisions as well as decisional responsibility when problems related to AI use arise. 

Authors: Gregory A. Abel, M.D., M.P.H., of the Dana-Farber Cancer Institute in Boston, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.4077)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Industry Payments to US Physicians by Specialty and Product Type

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 28, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.1989?guestAccessKey=09640006-76f3-4829-94b9-b6839dfb0eb8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032824

 

About The Study: From 2013 to 2022, U.S. physicians received $12.1 billion from industry. More than half of physicians received at least one payment. Payments varied widely between specialties and between physicians within the same specialty. A small number of physicians received the largest amounts, often exceeding $1 million, while the median physician received much less, typically less than a hundred dollars.  

Authors: Andrew J. Foy, M.D., of the Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania, is the corresponding author.

 

(doi:10.1001/jama.2024.1989)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Validation of a Multivariable Model to Predict Suicide Attempt in a Mental Health Intake Sample

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.0189?guestAccessKey=445000b7-be42-4847-93be-01620f9ad3e5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032724

No Comments

Filed under:

Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2024.0118?guestAccessKey=25867b4d-87f5-4bd0-a133-a32e5764ec8e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032724

No Comments

Filed under:

Estimated Sustainable Cost-Based Prices for Diabetes Medicines

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 27, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.3474?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032724

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: High prices limit access to newer diabetes medicines in many countries. The findings of this study suggest that robust generic and biosimilar competition could reduce prices to more affordable levels and enable expansion of diabetes treatment globally. 

Authors: Melissa J. Barber, Ph.D., of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency in New Haven, Connecticut, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.3474)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Physical Activity and Incident Obesity Across the Spectrum of Genetic Risk for Obesity

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 27, 2024

Media advisory: The full is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.3821?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032724

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Individuals at high genetic risk of obesity needed higher daily step counts to reduce the risk of obesity than those at moderate or low genetic risk in this study of 3,124 adults. Population-based recommendations may underestimate physical activity needed to prevent obesity among those at high genetic risk. 

Authors: Evan L. Brittain, M.D., M.Sc., and Douglas M. Ruderfer, Ph.D., of the Vanderbilt University Medical Center in Nashville, are the corresponding authors.

 

 (doi:10.1001/jamanetworkopen.2024.3821)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Health Equity Adjustment and Hospital Performance in the Medicare Value-Based Purchasing Program

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.2440?guestAccessKey=6957fb97-1427-4062-bcf1-a39d474109e9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032724

No Comments

Filed under:

Effectiveness of an AI–Enabled Intervention for Detecting Clinical Deterioration

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.0084?guestAccessKey=d189234d-dca9-4086-85ff-f86a2a8d7980&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032524

No Comments

Filed under:

AI Simulation of Adolescents’ Responses to Vaping-Prevention Messages

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.0274?guestAccessKey=22ee381c-a4d2-4d54-8e64-b9e74bf4973b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032524

No Comments

Filed under:

Inappropriate Diagnosis of Pneumonia Among Hospitalized Adults

Posted by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 25, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.0077?guestAccessKey=a23d981e-6f73-4e6f-b460-4436d2949b35&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032524

 

About The Study: Inappropriate diagnosis of community-acquired pneumonia was common, particularly among older adults, those with dementia, and those presenting with altered mental status in this study of 17,000 hospitalized adults treated for pneumonia in 48 Michigan hospitals. Full-course antibiotic treatment of those inappropriately diagnosed with community-acquired pneumonia may be harmful. 

Authors: Ashwin B. Gupta, M.D., of the VA Ann Arbor Healthcare System in Ann Arbor, Michigan, is the corresponding author.

 

(doi:10.1001/jamainternmed.2024.0077)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Development of a Follow-Up Measure to Ensure Complete Screening for Colorectal Cancer

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 25, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.2693?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this observational study of 20,000 adults suggest that a measure of follow-up colonoscopy within defined periods after an abnormal result of a stool-based screening test for colorectal cancer is warranted based on low current performance rates and would be feasible to collect by health systems and produce valid, reliable results. 

Authors: Elizabeth L. Ciemins, Ph.D., M.P.H., M.A., of the American Medical Group Association in Alexandria, Virginia, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.2693)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Job Flexibility, Job Security, and Mental Health Among Working Adults

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 25, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.3439?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study of 18,000 adults who were employed, greater job flexibility was significantly associated with reduced odds of experiencing serious psychological distress and experiencing anxiety. Greater job security was significantly associated with reduced odds of experiencing serious psychological distress and experiencing anxiety. 

Authors: Monica L. Wang, Sc.D., M.S., of the Boston University School of Public Health, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2024.3439)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women’s Health Organization Decision

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11:05 A.M. (ET), MONDAY, MARCH 25, 2024

Media advisory: The full study and Viewpoint are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.4266?guestAccessKey=278137b8-83fa-4db2-81fa-39f8f33f53a5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032524

 

About The Study: Provision of medications for self-managed abortions increased in the six months following the Dobbs v Jackson Women’s Health Organization decision. Results suggest that a substantial number of abortion seekers accessed services despite the implementation of state-level bans and restrictions. 

Authors: Abigail R. A. Aiken, Ph.D., of the University of Texas at Austin, is the corresponding author.

 

(doi:10.1001/jama.2024.4266)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under: